The FDA on Tuesday rejected a skin therapy from Replimune Group, suggesting a hardened stance on drug approvals under new ...

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...

Sarepta will halt all shipments of Elevidys, its drug for Duchenne muscular dystrophy patients, by Tuesday evening.

The biotechnology company Sarepta Therapeutics has decided to suspend entirely one of its treatments for Duchenne muscular dystrophy (DMD) just days after it refused a request from the US Food and ...

Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy appeared at risk.

The Decision to Begin Therapy Reviewed by Psychology Today Staff Most people—even those with a strong support system and no diagnosable mental illness—can benefit from therapy at some point in ...

We’re told to trust our gut when it comes to decision-making—but we also know that our gut can lead us astray. This is where CBT, or cognitive behavioral therapy, can be extremely useful.

The FDA is set to decide on MDMA therapy for PTSD, a move that could revolutionize treatment for veterans and others with severe trauma. Here's what's at stake ...

New Decision Therapy Christina Heike, New York, NY, 10003, (646) 920-5827, The practice New Decision Therapy was designed to heal those who have less than ideal relationships with themselves and ...

Among 2,143 patients on advanced therapy, 19% were prescribed janus kinase (JAK) inhibitors, 57% of whom were prescribed JAK inhibitors as monotherapy and 43% as combination therapy.